HansBiomed Corporation (KOSDAQ:042520)

HansBiomed Revenue

HansBiomed had revenue of 34.49B KRW in the quarter ending March 31, 2026, with 42.77% growth. This brings the company's revenue in the last twelve months to 110.50B, up 30.99% year-over-year. In the fiscal year ending September 30, 2025, HansBiomed had annual revenue of 89.78B with 10.65% growth.

• Revenue (ttm): 110.50B
• Revenue Growth: +30.99%
• P/S Ratio: 3.28
• Revenue / Employee: 372.05M
• Employees: 297
• Market Cap: 362.24B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2025	89.78B	8.64B	10.65%
Sep 30, 2024	81.14B	3.11B	3.98%
Sep 30, 2023	78.03B	3.57B	4.80%
Sep 30, 2022	74.46B	15.36B	25.99%
Sep 30, 2021	59.10B	-21.00B	-26.22%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 13, 2026

Data Sources Report a data error